Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococcus aureus (0019 + methicillin-resistant) |
- |
- |
7.8 - ? |
Apigenin |
138 |
Staphylococcus aureus (0019 + methicillin-resistant) |
- |
- |
15.6 - ? |
SB1 |
138 |
Staphylococcus aureus (0019 + methicillin-resistant) |
- |
- |
125 - ? |
Luteolin |
138 |
Staphylococcus aureus (0019 + methicillin-resistant) |
- |
- |
500 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
138 |
Staphylococcus aureus (0019 + methicillin-resistant) |
- |
- |
1000 - ? |
Meticillin (Methicillin, Staphcillin) |
138 |
Staphylococcus aureus (0020 + methicillin-resistant) |
- |
- |
1 - 138 |
Vancomycin (Vancocyn, Lyphocin) |
138 |
Staphylococcus aureus (0020 + methicillin-resistant) |
- |
- |
3.9 - ? |
Apigenin |
138 |
Staphylococcus aureus (0020 + methicillin-resistant) |
- |
- |
4 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
138 |
Staphylococcus aureus (0020 + methicillin-resistant) |
- |
- |
7.8 - ? |
SB1 |
138 |
Staphylococcus aureus (0020 + methicillin-resistant) |
- |
- |
15.6 - ? |
Meticillin (Methicillin, Staphcillin) |
138 |
Staphylococcus aureus (0020 + methicillin-resistant) |
- |
- |
125 - ? |
Luteolin |
138 |
Staphylococcus aureus (004-737X + linezolid-resistant) |
- |
- |
0.5 - ? |
TR-700 |
192 |
Staphylococcus aureus (004-737X + linezolid-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
192 |
Staphylococcus aureus (004-737X + linezolid-resistant) |
- |
- |
>2 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
192 |
Staphylococcus aureus (004-737X + linezolid-resistant) |
- |
- |
8 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
192 |
Staphylococcus aureus (011CB20 + constitutively erythromycin-resistant) |
- |
- |
40 - ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
58 |
Staphylococcus aureus (011CB20 + constitutively erythromycin-resistant) |
- |
- |
40 - ? |
Clarithromycin (Biaxin) |
58 |
Staphylococcus aureus (011CB20 + constitutively erythromycin-resistant) |
- |
- |
40 - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
58 |
Staphylococcus aureus (011GO25i + inducibly erythromycin-resistant) |
- |
- |
0.08 - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
58 |
Staphylococcus aureus (011GO25i + inducibly erythromycin-resistant) |
- |
- |
40 - ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
58 |
Staphylococcus aureus (011GO25i + inducibly erythromycin-resistant) |
- |
- |
40 - ? |
Clarithromycin (Biaxin) |
58 |
Staphylococcus aureus (011GO64 + erythromycin-resistant + ofloxacin-resistant + oxacilli) |
- |
- |
≥0.04 - ? |
Novobiocin (Albamycin) |
33 |
Staphylococcus aureus (011HT1 + novobiocin-resistant) |
- |
- |
0.6 - ? |
Clorobiocin |
33 |
Staphylococcus aureus (011HT1 + novobiocin-resistant) |
- |
- |
10 - ? |
Novobiocin (Albamycin) |
33 |
Staphylococcus aureus (011HT3) |
- |
- |
<0.04 - ? |
Novobiocin (Albamycin) |
33 |
Staphylococcus aureus (011UC4 + erythromycin-susceptible) |
- |
- |
0.04 - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
58 |
Staphylococcus aureus (011UC4 + erythromycin-susceptible) |
- |
- |
0.3 - ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
58 |
Staphylococcus aureus (011UC4 + erythromycin-susceptible) |
- |
- |
0.3 - ? |
Clarithromycin (Biaxin) |
58 |